当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Subrahmanyam V
Diabetes is associated with most of the risk factors associated to the vital organs like Heart, Kidney, Liver and Brain. Although there is no much evidence to understand the clear mechanism of the Diabetic Cardiomyopathy to have increased Heart Risk, it becomes very important to understand the possibilities or the available hypothesis to have a clear picture of the known latest research. Since decades Cardiologists are putting their efforts in understanding what are the possible risks and how to overcome them it was not really easy for them to finalize various Hypothesis. Thus, this field still provides wide opportunity for the young scientists to lay their efforts on finding out the proper mechanism in this not much explored medical condition. This review tries to understand the major advancements that have happened in the research concerned to the Diabetic Cardiomyopathy. We have tried to have an overview on the Biochemical and Molecular reasons that support DCM.